论文部分内容阅读
目的:探讨米非司酮配伍米索前列醇治疗瘢痕子宫宫内残留物的临床疗效。方法:将收治的44例各种难治宫内残留患者,随机分为观察组和对照组,对照组在抗炎治疗后行清宫术,观察组采用米非司酮配伍米索前列醇治疗后行清宫术,比较两组的临床疗效。结果:观察组的术中宫颈松弛率为100%,腹痛者0例,出血量为(45±15)ml,宫内残留0例,与对照组比较,差异有统计学意义(P<0.05)。结论:米非司酮配伍米索前列醇治疗瘢痕子宫宫内残留物临床疗效较好,且操作简单有效,可降低清宫术的并发症。
Objective: To investigate the clinical efficacy of mifepristone combined with misoprostol in the treatment of uterine uterine residue in scars. Methods: Forty-four patients with intrauterinetic refractory intrauterine rupture were randomly divided into observation group and control group. The control group underwent curettage after anti-inflammatory treatment. The patients in observation group were treated with mifepristone and misoprostol Clearing Palace surgery, the clinical efficacy of the two groups were compared. Results: The intraoperative rate of cervical relaxation was 100% in the observation group, 0 in the abdominal pain group, the amount of bleeding was (45 ± 15) ml and the intrauterine residual group was 0. The difference was statistically significant (P <0.05) . Conclusion: Mifepristone combined with misoprostol in the treatment of uterine uterine residue in the clinical curative effect is better, and the operation is simple and effective, can reduce the complications of curettage.